These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1067 related items for PubMed ID: 19135996

  • 1. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E, Delgado M.
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E, Chorny A, Varela N, O'Valle F, Delgado M.
    Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
    [Abstract] [Full Text] [Related]

  • 8. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ, Yan L, Wang CZ, Wang WH, Shi H, Su BB, Zeng QH, Du HT, Wan J.
    World J Gastroenterol; 2013 Aug 07; 19(29):4702-17. PubMed ID: 23922467
    [Abstract] [Full Text] [Related]

  • 9. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM.
    J Pharmacol Exp Ther; 2008 Jan 07; 324(1):23-33. PubMed ID: 17911375
    [Abstract] [Full Text] [Related]

  • 10. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.
    Zhou B, Yuan J, Zhou Y, Ghawji M, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ.
    Clin Immunol; 2011 Dec 07; 141(3):328-37. PubMed ID: 21944669
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
    Wen Q, Zhou L, Chen H, Zhang Y.
    J Gastroenterol Hepatol; 2013 Aug 07; 28(8):1330-8. PubMed ID: 23663055
    [Abstract] [Full Text] [Related]

  • 14. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L, Dong C, Chen X, Fang Z, Xu J, Liu M, Zhang X, Gu DS, Wang D, Du W, Zhu D, Han ZC.
    Cell Transplant; 2011 Aug 07; 20(9):1395-408. PubMed ID: 21396175
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS, Shin TH, Lee BC, Yu KR, Seo Y, Lee S, Seo MS, Hong IS, Choi SW, Seo KW, Núñez G, Park JH, Kang KS.
    Gastroenterology; 2013 Dec 07; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [Abstract] [Full Text] [Related]

  • 18. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.
    Shlomai A, Trop S, Gotsman I, Jurim O, Diment J, Alper R, Rabbani E, Engelhardt D, Ilan Y.
    J Pathol; 2001 Nov 07; 195(4):498-507. PubMed ID: 11745683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J, Lee EN, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Lee KW, Kwon GY, Joh JW, Kim SJ.
    Immunol Lett; 2005 Nov 15; 101(2):210-6. PubMed ID: 16026855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.